ArticleJournal of nanobiotechnology2025

Rational design of a triple-type HPV53/56/66 vaccine with one preferable base particle incorporating two identified immunodominant sites.

Ciying Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.